BIO Deutschland participates in HealthTech Innovation Days (HTID3) in Paris

The third edition of the HealthTech Innovation Days (HTID3) took place on 4–5 October in Paris and with virtual participation. Kathrin Adlkofer, a member of the BIO Deutschland board, moderated the panel on „Clinical research as a care option and an added value for innovative companies“. She discussed live with Elena Coluccelli, Managing Partner at Transaction Rothschild & Co; Victoria diBiaso, Global Head of Patient Informed Development & Health Value Translation at Sanofi; and Karine Samama, Healthcare and Life Science Strategy Director at Microsoft France.

BIO Deutschland has been a partner of the HTID in Paris since 2021 and supports the HealthTech For Care-organized event by arranging speakers and providing publicity.